-transparent.png){kind=logo}
Multipotent mesenchymal stem cells (MSCs) represent a great candidate for various clinical applications including regenerative medicine. However, aging both in vivo and in vitro can significantly compromise MSC characteristics and performance. This paper highlights current thoughts on senescence-induced damage to MSCs that should be considered prior to their use for regeneration of different cells, tissues or organs.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Yueh-Hsun Kevin Yang
July 2012,
Muscles, ligaments and tendons journal,
Yueh-Hsun Kevin Yang
January 2018,
Stem cells international,
Yueh-Hsun Kevin Yang
January 2020,
Frontiers in cell and developmental biology,
Yueh-Hsun Kevin Yang
January 2018,
Advances in experimental medicine and biology,
Yueh-Hsun Kevin Yang
January 2022,
Advances in experimental medicine and biology,
Yueh-Hsun Kevin Yang
May 2016,
Artificial cells, nanomedicine, and biotechnology,
Yueh-Hsun Kevin Yang
January 2017,
Bio-medical materials and engineering,
Yueh-Hsun Kevin Yang
February 2022,
Minerva medica,
Yueh-Hsun Kevin Yang
January 2013,
Stem cells international,
